Drug intelligence / Profile preview

differentiation-inducing factor-1

Development stage
Preclinical
Modality
Small Molecules
Administration
In Vitro, Intragastric (preclinical/animal Model Only)
01

Overview

Differentiation-inducing factor-1 (**DIF-1**) is a small molecule polyketide originally identified in the slime mold *Dictyostelium discoideum* as a morphogen that induces prestalk cell differentiation[3][5][6]. In mammalian cells, especially various cancer cell lines, DIF-1 is known to exert **anti-proliferative effects** by multiple mechanisms: it induces cell cycle arrest at G1, suppresses the expression of cyclin D1, inhibits phosphorylation and activity of cyclin-dependent kinases (Cdk4, Cdk6, Cdk2), reduces levels of signal transducer and activator of transcription 3 (STAT3) via inhibition of translation, and downregulates activity of ribosomal protein S6 kinase (p70S6K/p85S6K)[1][2]. DIF-1 can also promote differentiation in vascular smooth muscle cells and upregulate specific smooth muscle markers[2]. In rodent models, intragastric administration of DIF-1 reduces tumor growth without noticeable adverse effects[1].

Other names
differentiation inducing factor 1DIF1DIF-1DIF 1Dictyostelium differentiation-inducing factor-1
02

Targets

CCND1 (Cyclin D1)MDH2 (Mitochondrial Malate Dehydrogenase)PDE1 (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase)S6K1/S6K2 (Ribosomal protein S6 kinase beta-1/beta-2)STAT3 (Signal Transducer and Activator of Transcription 3)CDK2 (Cyclin-dependent kinase 2)CDK4 (Cyclin-dependent kinase 4)CDK6 (Cyclin-dependent kinase 6)RPS6KB1 (Ribosomal protein S6 kinase beta-1)

Beyond the preview

Go deeper on differentiation-inducing factor-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on differentiation-inducing factor-1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call